A Phase Ia/Ib Open Label，Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors
Clinical trial NCT05868876 · RECRUITING
Trial details
- NCT number
- NCT05868876
- Sponsor
- Akeso
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-29
- Primary completion
- 2025-11-01
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.